87 related articles for article (PubMed ID: 21371237)
1. Increased detection of the HIV-1 reverse transcriptase M184V mutation using mutation-specific minority assays in a UK surveillance study suggests evidence of unrecognized transmitted drug resistance.
Buckton AJ; Prabhu D; Motamed C; Harris RJ; Hill C; Murphy G; Parry JV; Johnson JA; Lowndes CM; Gill N; Pillay D; Cane PA
HIV Med; 2011 Apr; 12(4):250-4. PubMed ID: 21371237
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations.
Vega Y; Delgado E; Fernández-García A; Cuevas MT; Thomson MM; Montero V; Sánchez M; Sánchez AM; Pérez-Álvarez L;
PLoS One; 2015; 10(5):e0125699. PubMed ID: 26010948
[TBL] [Abstract][Full Text] [Related]
3. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
Peuchant O; Thiébaut R; Capdepont S; Lavignolle-Aurillac V; Neau D; Morlat P; Dabis F; Fleury H; Masquelier B;
AIDS; 2008 Jul; 22(12):1417-23. PubMed ID: 18614864
[TBL] [Abstract][Full Text] [Related]
4. HIV type-1 drug resistance in treatment-naive patients monitored using minority species assays: a systematic review and meta-analysis.
Buckton AJ; Harris RJ; Pillay D; Cane PA
Antivir Ther; 2011; 16(1):9-16. PubMed ID: 21311104
[TBL] [Abstract][Full Text] [Related]
5. Rapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® System.
Cheung KW; Peng Q; He L; Cai K; Jiang Q; Zhou B; To SW; Yam WC; Liu L; Chen Z; Wang H
PLoS One; 2016; 11(4):e0153641. PubMed ID: 27092551
[TBL] [Abstract][Full Text] [Related]
6. Minority HIV-1 resistant variants in recent infection and in patients who failed first-line antiretroviral therapy with no detectable resistance-associated mutations in Thailand.
Le Nguyen H; Pitakpolrat P; Sirivichayakul S; Delaugerre C; Ruxrungtham K
J Med Virol; 2012 May; 84(5):713-20. PubMed ID: 22431018
[TBL] [Abstract][Full Text] [Related]
7. Efficient suppression of minority drug-resistant HIV type 1 (HIV-1) variants present at primary HIV-1 infection by ritonavir-boosted protease inhibitor-containing antiretroviral therapy.
Metzner KJ; Rauch P; von Wyl V; Leemann C; Grube C; Kuster H; Böni J; Weber R; Günthard HF
J Infect Dis; 2010 Apr; 201(7):1063-71. PubMed ID: 20196655
[TBL] [Abstract][Full Text] [Related]
8. Transmission dynamics of the M184V drug resistance mutation in primary HIV infection.
Wainberg MA; Moisi D; Oliveira M; Toni TD; Brenner BG
J Antimicrob Chemother; 2011 Oct; 66(10):2346-9. PubMed ID: 21750100
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of antiretroviral drug resistance in antiretroviral-naive individuals.
James CW; Moffett LE; Szabo S
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):193-5. PubMed ID: 19414829
[TBL] [Abstract][Full Text] [Related]
10. HIV reverse-transcriptase drug resistance mutations during early infection reveal greater transmission diversity than in envelope sequences.
Lipscomb JT; Switzer WM; Li JF; Masciotra S; Owen SM; Johnson JA
J Infect Dis; 2014 Dec; 210(11):1827-37. PubMed ID: 24924164
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of minority populations of HIV type-1 with K103N and M184V drug resistance mutations among children in Argentina.
Vignoles M; Barboni G; Agosti MR; Quarleri J; García MK; Ayala SG; Salomón H
Antivir Ther; 2009; 14(8):1175-81. PubMed ID: 20032547
[TBL] [Abstract][Full Text] [Related]
12. Deep sequencing does not reveal additional transmitted mutations in patients diagnosed with HIV-1 variants with single nucleoside reverse transcriptase inhibitor resistance mutations.
Pingen M; van der Ende ME; Wensing AM; el Barzouhi A; Simen BB; Schutten M; Boucher CA
HIV Med; 2013 Mar; 14(3):176-81. PubMed ID: 22989004
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.
Romero A; Sued O; Puig T; Esteve A; Pumarola T; Casabona J; González V; Matas L; Tural C; Rodrigo I; Margall N; Domingo P; Casanova A; Ferrer E; Caballero E; Ribera E; Farré J; Puig T; Amengual MJ; Navarro G; Prat JM; Masabeu A; Simó JM; Villaverde CA; Barrufet P; Sauca MG; Ortin X; Ortí A; Navarro R; Euras JM; Vilaró J; Villà MC; Montull S; Vilanova C; Pujol F; Díaz O; Miró JM;
Enferm Infecc Microbiol Clin; 2011; 29(7):482-9. PubMed ID: 21543135
[TBL] [Abstract][Full Text] [Related]
14. New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines.
Read P; Costelloe S; Mullen J; O'Shea S; Lyons F; Hay P; Welch J; Larbalestier N; Taylor G; de Ruiter A
HIV Med; 2008 Aug; 9(7):448-51. PubMed ID: 18840150
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.
Shafer RW; Rhee SY; Pillay D; Miller V; Sandstrom P; Schapiro JM; Kuritzkes DR; Bennett D
AIDS; 2007 Jan; 21(2):215-23. PubMed ID: 17197813
[TBL] [Abstract][Full Text] [Related]
16. The M184V mutation: what it does, how to prevent it, and what to do with it when it's there.
Gallant JE
AIDS Read; 2006 Oct; 16(10):556-9. PubMed ID: 17096474
[TBL] [Abstract][Full Text] [Related]
17. Minority HIV-1 drug-resistant mutations and prevention of mother-to-child transmission: perspectives for resource-limited countries.
Samuel R; Paredes R; Parboosing R; Moodley P; Gordon M
AIDS Rev; 2014; 16(4):187-98. PubMed ID: 25300623
[TBL] [Abstract][Full Text] [Related]
18. Does the M184V resistance mutation in reverse transcriptase reduce HIV transmission?
Turner D
HIV Med; 2011 Apr; 12(4):193-4. PubMed ID: 21371236
[No Abstract] [Full Text] [Related]
19. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L
Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198
[TBL] [Abstract][Full Text] [Related]
20. Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.
Zaccarelli M; Perno CF; Forbici F; Cingolani A; Liuzzi G; Bertoli A; Trotta MP; Bellocchi MC; Di Giambenedetto S; Tozzi V; Gori C; D'Arrigo R; De Longis P; Noto P; Girardi E; De Luca A; Antinori A
Antivir Ther; 2003 Feb; 8(1):51-6. PubMed ID: 12713064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
